OBJECTIVES: Partial atrioventricular septal defect ( pAVSD) is routinely repaired with a low mortality. However, limited data are available on the long-term follow-up of these patients. The current study was designed to determine long-term survival and morbidity of a large cohort of patients operated on at a single institution.
INTRODUCTION
The spectrum of atrioventricular septal defects makes up 7-17% of congenital heart disease [1] , of which partial atrioventricular septal defects (pAVSDs) constitute 25% [2] . Typically, pAVSD is repaired in the preschool years, or earlier if signs of heart failure develop. An operative mortality rate of 1.6-13% [3] [4] [5] [6] [7] [8] [9] [10] and a long-term survival rate of 78-85% at 30-years follow-up [3, 5] have been reported. The reoperation rate ranges from 17 to 20% at 30-years follow-up [3, 5] . Here, we review our results with an emphasis on long-term follow-up.
MATERIALS AND METHODS

Patients
Between January 1975 and January 2012, 249 consecutive patients underwent surgical correction of a pAVSD at the Royal Children's Hospital, Melbourne, and were included in the present retrospective review. Ethics approval was granted by the Royal Children's Hospital Human Research Ethics Committee.
Data were obtained by retrospective review of patient records and follow-up was obtained by correspondence with the patient's cardiologist or general practitioner. Patients were contacted by telephone and asked to complete a questionnaire if no current medical practitioner could be identified. For patients who were lost to follow-up, the Victorian registry of Birth Deaths and Marriages was searched for death records.
Early postoperative LAVVR was defined as LAVVR as measured on postoperative transthoracic echocardiography during the initial admission.
Left atrioventricular valve (LAVV) stenosis was defined as a left atrium to left ventricular diastolic pressure gradient >5 mmHg or operation for LAVV stenosis.
Left ventricular outflow tract obstruction (LVOTO) was defined as a gradient of >20 mmHg across the LVOT or surgery for LVOTO [12] .
Early mortality was defined as death occurring prior to hospital discharge or within 30 days of operation.
Complete LAVV cleft closure was defined as direct closure of the entire cleft of the left atrioventricular valve to the chordal attachment. Partial cleft closure was defined as any degree of incomplete closure of the cleft.
Clinically significant arrhythmia was defined as any arrhythmia on discharge from the hospital that required medication or implantation of a permanent pacemaker or implantable cardiac defibrillator.
Complete cardiology follow-up was considered to have occurred when a patient had been reviewed by a cardiologist on or after 1 January 2012.
Operative procedure
The repair of pAVSD was performed through a median sternotomy with bicaval cannulation and cardiopulmonary bypass with hypothermic cardioplegic arrest. The decision to close the cleft in the LAVV was made at the surgeon's discretion, depending on the degree of LAVVR on preoperative echocardiogram and as assessed at surgery with normal saline infusion. The ostium primum defect was repaired with an autologous pericardial patch. In a small number of patients prior to 1990 Dacron (7 patients) or Teflon felt (2 patients) patches or direct suture closure (2 patients) were used to repair the ostium primum defect. Hypothermic circulatory arrest was used only in 10 patients operated on prior to 1990.
Statistical analysis
Data were analysed with STATA version 12 (Stata Corp., College Station, TX, USA). Unless stated to the contrary, continuous data were summarized as mean ± standard deviation. The time-dependent end-points investigated were: all-cause mortality, the first cardiac reoperation, the first reoperation for LAVV regurgitation and the first reoperation for LVOTO. For all end-points, time was measured starting from repair for pAVSD. Reoperation times were considered to have been censored in the event of death (but not other types of reoperation). Kaplan-Meier analysis was used to estimate survival and freedom from reoperation. Cox proportional hazards regression was used to examine risk factors for mortality, first reoperation and first reoperation for LAVVR. The risk factors examined were: age, sex, trisomy 21 status, presence of associated congenital heart defects, previous operation, congestive heart failure (CHF), degree of pre-operative LAVVR, decade of operation, cleft closure and additional surgical procedures and degree of early post-operative LAVVR. Where appropriate, for analysis continuous variables were converted to z-scores to allow better comparison of estimated hazard ratios between continuous and binary factors. For mortality, univariable analysis only was performed due to the small number of deaths (12 in total). For the reoperation end-points, factors with large effect size (HR >2.0 or HR <0.5) together with moderate evidence against the null hypothesis (P < 0.25) upon univariable analysis were considered for inclusion in the multivariable model. Owing to the small number of first reoperations and first reoperations for LAVV regurgitation among patients with complete covariate data (29 and 19 in total, respectively), these multivariable models were restricted to three and two factors, respectively. Test of the proportional hazards assumption was based on Schoenfeld residuals. For patients known to be alive at the end of the study, completeness of cardiology follow-up between patients younger than 18 years and patients older than 18 years on 1 January 2012 was compared using a χ 2 test.
RESULTS
Patient demographics
Demographic data are summarized in Table 2 .
Intraoperative details
Intraoperative data are summarized in Table 1 . The mean cardiopulmonary bypass time was 78.9 ± 30.0 min, while the mean aortic cross-clamp time was 50.3 ± 22.0 min. The cleft in the LAVV was completely closed in 66% (164/249), partially closed in 15% (37/249) and not closed in 19% (48/249). Additional concurrent procedures were performed on 139 (55.8%) patients who underwent a total of 183 additional procedures, which are detailed in Table 2 . Briefly, the most common were patent foramen ovale or secundum atrical septal defect (ASD) closure in 35.3% (88/249), ventricular septal defect (VSD) closure in 10.8% (27/249), additional procedures on the LAVV in 8.8% (22/249) and patent ductus arteriosus ligation in 7.2% (18/249).
Survival
The mean follow-up for patients was 15.1 ± 9.8 years spanning 1 day to 37.5 years, with 204 patients (82%) having complete follow-up (last follow-up for survivors occurred on or after 1 January 2012).
Three patients died in the hospital, making the early mortality rate 1.2% (3/249). The first patient was a 3-week old girl operated on in 1987, transferred from a peripheral hospital in extremis. She had a double orifice LAVV, multiple muscular VSDs, severe right atrioventricular valve regurgitation and pulmonary hypertension. On the first day after complete repair the patient had a cardiac arrest and could not be resuscitated. The second patient was a 3-week old boy operated on in 1993, with a severely regurgitant, dysplastic LAVV. He was ventilator dependent following subclavian flap repair for aortic coarctation. Following complete repair of pAVSD, multiple attempts to wean off inotropes resulted in severe pulmonary congestion. Mitral valve replacement was performed but the patient could not be weaned off bypass and treatment was withdrawn. The third patient was a 4-month old boy operated on in 2007, with pAVSD, down syndrome, secundum ASD, pulmonary hypertension and chronic lung disease. The child had a cardiac arrest preoperatively, was rushed to the operating room and placed on cardiopulmonary bypass. After complete repair of the pAVSD, the patient was brought to the ICU with extracorporeal membrane oxygenator (ECMO) support. The patient developed sepsis and persistent pulmonary hypertension. The ECMO was withdrawn on the 11th postoperative day and the patient died.
The late mortality rate among hospital survivors was 3.6% (9/ 246). Survival is illustrated in Fig. 1 and Table 3 . The survival rate at 10 and 30 years was 96% (95% CI: 93-98%) and 94% (95% CI: 89-97%), respectively. By univariable analysis (Table 4) , higher age at pAVSD repair (HR = 0.22; 95% CI: 0.1-0.5) and closure of the LAVV cleft (HR = 0.08; 95% CI: 0.02-0.29) were the factors most likely to be associated with decreased risk of mortality, while preoperative CHF (HR = 14; 95% CI: 3.9-53) was associated with an increased risk of mortality. As noted in the statistical methods, multivariable analysis to separate the effects of these factors was not feasible due to the small number of deaths.
When patients with trivial to mild preoperative LAVVR were analysed as a separate group, older age at pAVSD repair (HR = 0.25; 95% CI: 0.1-0.6; P = 0.003) and closure of the cleft (HR = 0.12; 95% CI: 0.1-0.5; P = 0.003) remained predictors of better long-term survival, while preoperative CHF (HR = 22; 95% CI: 4.6-106; P < 0.001) and early postoperative moderate-to-severe LAVV regurgitation (HR = 8.2; 95% CI: 1.6-45; P = 0.011) were associated with increased risk of mortality.
Reoperations
A total of 67 reoperations were performed on 43 patients (18.7%), which are summarized in Table 5 . Freedom from reoperation is shown in Fig. 2 . Freedom from reoperation at the 10-and 30-year follow-up was 84% (95% CI: 78-88%) and 75% (95% CI: 67-81%), respectively. By univariable analysis (Table 6) , preoperative CHF (HR = 4.3; 95% CI: 2.3-8.0), cardiovascular surgery prior to pAVSD repair (HR = 3.2; 95% CI: 1.4-7.3), moderate-to-severe early postoperative LAVVR (HR = 7.3; 95% CI: 3.3-16) and older age at pAVSD repair (HR = 0.8; 95% CI: 0.7-0.96) were the factors most likely to be associated with reoperation. Under multivariable analysis, moderate to severe early postoperative LAVV regurgitation, preoperative CHF and cardiovascular surgery prior to pAVSD repair remained independently associated with increased risk of reoperation (Table 6) .
Reoperation for LAVVR was performed in 12.1% (30/249) of patients, who underwent a total of 39 LAVV procedures. By univariable analysis, preoperative CHF (HR = 4.4; 95% CI: 2.1-9.3), preoperative moderate to severe LAVV regurgitation (HR = 2.6; 95% CI: 1.2-5.4), younger age at pAVSD repair (in years) (HR = 0.8; 95% CI: 0.7-0.95) and moderate to severe early postoperative LAVVR (HR = 14.6, 95% CI: 5.9-36) were the factors most likely to be associated with later reoperation for LAVV regurgitation. Under multivariable analysis, both early postoperative LAVV regurgitation and preoperative CHF remained independently predictive of the need for repeat LAVV surgery (Table 6) .
Reoperation for LVOTO was performed in 12 patients (5.2%) who underwent a total of 16 LVOTO resections. Six reoperations for residual ASD were performed in 4 patients (2.0%), while 2 patients had reoperation for residual VSD (0.8%). RAVV repair (n = 1), sub-pulmonary resection (n = 1), orthotopic heart transplant (n = 1), left ventricular assist device implantation (n = 1). The number of factors entered into each model was limited according to the number of observed first reoperations for that outcome.
stenosis. Surgery for LAVV stenosis was performed in 2 patients (1.0%) both of whom had mixed LAVV stenosis and regurgitation.
Left ventricular outflow tract obstruction
Information on the status of the LVOT was available for 200 patients (84%): 173 patients were free of LVOTO (86%), 15 patients (8%) had LVOTO that had not required surgery and 12 patients (6%) had LVOTO resection.
Arrhythmias
Documented information on arrhythmias was available for 202 patients, of whom 13 patients (6.4%) had a clinically significant arrhythmia. Arrhythmias identified were atrial fibrillation in 1.5% (3/ 202), supraventricular tachycardia in 1.5% (3/202), sick sinus syndrome in 1.5% (3/202) and heart block in 2.0% (4/202). Permanent pacemakers were implanted in 3.2% of the patients (8/249), for heart block (Mobitz type II, n = 1 and complete heart block, n = 3) and for sick sinus syndrome (n = 4).
Cardiology follow-up for local patients
Of the 235 local patients, there were 200 patients for whom the date of their last visit to a cardiologist was known. The median duration of cardiology follow-up for these patients was 10.6 years (interquartile range: 5.3-17.3 years). Among these 200 patients, 177 were known to be alive at the end of the study on 1 January 2012, with 98 patients (55%) under 18 years of age. For patients under 18 years of age, 78 (80%) were seen by a cardiologist after 1 January 2012, compared with 34 patients (43%) over 18 years of age (P < 0.001).
COMMENT
Complete repair of pAVSD was first performed at the Royal Children's Hospital in 1975. The current study was designed to review the longterm outcomes for pAVSD repair at a single institution. The operative mortality rate of 1.2% in our study was lower compared with other studies, which have generally reported an early mortality rate in the range of 1.6-5% for pAVSD repair performed in children [3] [4] [5] [6] [7] [8] . In contrast, Baufreton et al. [9] in a cohort of 100 patients operated on from 1989 to 1993 reported an early mortality rate of 13%, but included both partial and intermediate AVSD repair, while Agny et al. [10] in a cohort of 51 patients undergoing pAVSD repair from 1981 to 1997, with a relatively lower mean age of 22 months, reported an early mortality rate of 7.9%.
The long-term survival rate was 96% at 10 years and 94% at 30 years, respectively. This compared favourably with other studies, which have demonstrated survival rates of 93-98% at the 10-year and 78-85% at the 30-year follow-up, respectively [3] [4] [5] . Older age at time of operation and closure of the LAVV cleft were predictors of better long-term survival, while preoperative CHF was a risk factor for death.
The present study found reoperation rates of 16% at 10 years and 25% at 30 years, which were somewhat higher than in previous studies, which have varied by 17 to 20% at the 30-year follow-up [3, 5] . It is unclear from the current study whether the improved survival of our patients resulted in more patients surviving long enough to require a reoperation or if a more aggressive reoperation strategy resulted in improved survival. This improved survival of our patients is, however, consistent with the findings of Stulak et al. [13] , who, in a cohort of 96 patients undergoing reoperation following pAVSD between 1962 and 2006, demonstrated that reoperation following pAVSD repair could be performed with good long-term survival.
Freedom from LAVV reintervention was 77% at 30 years. Reoperation for LAVV surgery was strongly associated with the presence of early postoperative moderate to severe LAVV regurgitation. Freedom from surgery for LVOTO was 92% at the 30-year follow-up. LVOTO requiring surgery has previously been described to occur in 10% of patients at the 10-year follow-up [4] and is multifactorial, related to intrinsic narrowing and elongation of the LVOT, malalignment of the aorta, squeezing of the LVOT by its muscular walls and anomalous insertion of the LAVV tension apparatus [14] .
Interestingly, in our cohort the year of operation did not influence the outcomes. This is in contrast to the findings of El-Najdawi et al. [3] , describing 334 patients undergoing pAVSD from 1955 to 1995, and Najm et al. [4] , who presented 180 patients undergoing pAVSD repair between 1982 and 1996, demonstrating a decrease in mortality in more recent years of their cohorts. Decreasing mortality over time is also demonstrated by comparing these more recent cohorts with historical results presented by Losay et al. [15] in a cohort of 92 patients operated on between 1955 and 1975. The present study enrolled patients from 1975 to 2011 inclusive, which represents a relatively more recent cohort, with approximately three-quarters of patients operated on after 1990. It is possible that many of the advancements in treatment that were introduced during the enrolment periods of other studies were present for the majority of cases included in this study. For example throughout the study period we have operated on patients at a younger age, compared with the series of Welke et al. [5] , and El-Najdawi et al. [3] , where in the earlier decades the mean patient age was 9-10 years. Likewise, there was no consistent trend to increasing rates of cleft closure over time, unlike in the cohort of Welke et al. [5] , where in more recent decades the rates of cleft closure were significantly higher.
An ongoing topic of contention has been whether the cleft in the LAVV should be closed in patients without significant LAVVR [16] . In the present study, as in other reports [3, 5, 6] , the decision to close the cleft was made by the surgeon based on the intraoperative examination of the valve. We have demonstrated that cleft closure is associated with improved survival, whether or not patients had significant preoperative LAVVR. This is in contrast to Al Hay et al. [6] , who, describing a cohort of 126 patients with pAVSD and trivial to mild LAVVR repaired between 1983 and 2003, concluded that the cleft should be left open if the LAVV is competent. It should be noted that they did not analyse long-term survival, probably due to their smaller cohort and shorter followup. Conversely, our results are consistent with other groups who analysed cohorts with LAVVR ranging from trivial to severe [3, 5] . Owing to the retrospective nature of the study we cannot prove causation, but this would seem to further support routine cleft closure as advocated by other groups [4, 16] .
Given the excellent survival, but higher reoperation rate found in our study, we believe that further improvement lies in thorough follow-up and reduction of long-term morbidity. A key component of this approach should be the maintenance of regular cardiology follow-up after transition to adult cardiology service. While patients tended to have good follow-up to the age of 18 years, thereafter follow-up fell to around 40%. This is consistent with the report by Mackie et al. [17] , who found that cardiology follow-up falls away with increasing age. Our current practice is to follow the patients with stable, repaired pAVSD in the cardiology clinic at two yearly intervals with transfer of care to an adult congenital clinic at the age of 18 years. We believe that, given the high level of reintervention, continuing up to 20 years postoperatively, it is important for an adult patients to continue regular follow-up to allow timely diagnosis and treatment of any long-term complications. This approach is consistent with up-to-date published guidelines [18, 19] .
The major limitation of this study is its retrospective nature. Furthermore, a low event rate, especially for mortality, may have reduced the accuracy of statistical analysis.
In conclusion, repair of pAVSD continues to be performed with low operative mortality and excellent long-term survival. There is a substantial need for late reoperation continuing up to 20 years postoperatively. This necessitates regular ongoing cardiology follow-up into adulthood.
